Gestia SR 300 Tablet contains 300 mg of natural micronized progesterone, a bioidentical hormone essential for regulating various physiological processes in the female reproductive system. This medication is primarily indicated for hormone replacement therapy (HRT) in women experiencing progesterone deficiency, including those undergoing menopause or postmenopausal hormone therapy to counterbalance estrogen effects and reduce the risk of endometrial hyperplasia. Gestia SR 300 is also utilized in the management of menstrual disorders such as amenorrhea, abnormal uterine bleeding, and luteal phase support in assisted reproductive techniques. The sustained-release formulation ensures a gradual and consistent release of progesterone, maintaining stable plasma levels and enhancing therapeutic efficacy while minimizing side effects. Progesterone acts by binding to intracellular progesterone receptors, modulating gene expression and promoting endometrial receptivity, thereby supporting pregnancy maintenance. This tablet should be administered under medical supervision, with dosage tailored according to the specific clinical indication and patient response. Contraindications include known hypersensitivity to progesterone, active thromboembolic disorders, liver dysfunction, and undiagnosed vaginal bleeding. Common adverse effects may include dizziness, headache, breast tenderness, and gastrointestinal discomfort. Regular monitoring is advised to assess therapeutic outcomes and detect any potential adverse reactions promptly.